MME
LH icon

Meag Munich Ergo’s Labcorp LH Stock Holding History

Meag Munich Ergo’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,730
Closed -$1.54M – 214
2024
Q4 		$1.54M Buy
6,730
+1,890
+39% +$434K 0.05% 124
2024
Q3 		$1.08M Buy
4,840
+237
+5% +$52.1K 0.03% 133
2024
Q2 		$937K Sell
4,603
-11,103
-71% -$2.26M 0.03% 130
2024
Q1 		$3.43M Buy
+15,706
New +$3.46M 0.12% 102
2021
Q3 		– Sell
-7,171
Closed -$1.7M – 280
2021
Q2 		$1.7M Buy
7,171
+3,919
+121% +$893K 0.16% 137
2021
Q1 		$713K Buy
+3,252
New +$653K 0.07% 215
2020
Q4 		– Sell
-5,879
Closed -$951K – 205
2020
Q3 		$951K Hold
5,879
– – 0.18% 128
2020
Q2 		$839K Hold
5,879
– – 0.16% 131
2020
Q1 		$638K Sell
5,879
-1,643
-22% -$237K 0.15% 119
2019
Q4 		$1.09M Sell
7,522
-7
-0.1% -$1.01K 0.12% 183
2019
Q3 		$1.07M Buy
7,529
+3,377
+81% +$493K 0.05% 341
2019
Q2 		$611K Hold
4,152
– – 0.05% 356
2019
Q1 		$537K Buy
4,152
+1,009
+32% +$124K 0.04% 382
2018
Q4 		$337K Hold
3,143
– – 0.04% 301
2018
Q3 		$459K Sell
3,143
-5,554
-64% -$845K 0.03% 349
2018
Q2 		$1.35M Sell
8,697
-11,730
-57% -$1.77M 0.08% 237
2018
Q1 		$2.82M Buy
20,427
+14,752
+260% +$2.17M 0.12% 231
2017
Q4 		$789K Sell
5,675
-33,703
-86% -$4.45M 0.03% 383
2017
Q3 		$5.08M Sell
39,378
-351,196
-90% -$46.8M 0.21% 143
2017
Q2 		$8.75M Buy
390,574
+351,560
+901% +$43.1M 0.39% 87
2017
Q1 		$4.81M Sell
39,014
-44,586
-53% -$5.28M 0.19% 178
2016
Q4 		$9.26M Buy
+83,600
New +$9.29M 0.43% 76
2015
Q4 		– Sell
-104,093
Closed -$9.66M – 264
2015
Q3 		$9.66M Buy
+104,093
New +$10.8M 0.52% 67

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meag Munich Ergo's LH Position: Q1 2025 in Review

Meag Munich Ergo sold out of Labcorp (LH) in Q1 2025, closing a stake of 6,730 shares — an estimated $1.54M sold.

Meag Munich Ergo first reported a position in LH in Q3 2015 and held it in 23 quarters. The position peaked at $9.66M in Q3 2015. 976 funds tracked by Wall St. Rank hold LH as of Q1 2025.

  • Meag Munich Ergo reported no remaining Labcorp position as of Q1 2025 after selling out during the quarter.
  • Meag Munich Ergo sold 6,730 Labcorp shares in Q1 2025, an estimated $1.54M.
  • Meag Munich Ergo first reported a position in Labcorp in Q3 2015 and held it in 23 quarters.
  • Meag Munich Ergo's Labcorp position peaked at $9.66M in Q3 2015.
  • 976 funds tracked by Wall St. Rank held Labcorp as of Q1 2025.

Based on Meag Munich Ergo's 13F filing for Q1 2025, filed 17 Apr 2025.